Asia Pacific Pharma Sector Analysis
November 2009
Table of Contents
1. Analyst View
2. Global Pharmaceutical Market Overview
2.1 Market Size and Growth
2.2 Leading Drugs
3. Asia-Pacific Pharmaceutical Market Overview
4. Pharmaceutical Market By Country
4.1 China
4.1.1 Market Overview
4.1.2 Future Outlook
4.1.3 Regulatory Environment
4.2 India
4.2.1 Market Overview
4.2.2 Future Outlook
4.2.3 Regulatory Environment
4.3 Japan
4.3.1 Market Overview
4.3.2 Future Outlook
4.3.3 Regulatory Environment
4.4 South Korea
4.4.1 Market Overview
4.4.2 Future Outlook
4.4.3 Regulatory Environment
4.5 Indonesia
4.5.1 Market Overview
4.5.2 Future Outlook
4.5.3 Regulatory Environment
4.6 Vietnam
4.6.1 Market Overview
4.6.2 Future Outlook
4.6.3 Regulatory Environment
4.7 Thailand
4.7.1 Market Overview
4.7.2 Future Outlook
4.7.3 Regulatory Environment
4.8 Philippines
4.8.1 Market Overview
4.8.2 Future Outlook
4.8.3 Regulatory Environment
4.9 Malaysia
4.9.1 Market Overview
4.9.2 Future Outlook
4.9.3 Regulatory Environment
4.10 Australia
4.10.1 Market Overview
4.10.2 Future Outlook
4.10.3 Regulatory Environment
4.11 New Zealand
4.11.1 Market Overview
4.11.2 Future Outlook
4.11.3 Regulatory Environment
5. Emerging Market Trends
5.1 Contract Manufacturing
5.2 Vaccine Market
5.3 Generics
5.4 Medical Tourism Market
6. Industry Restraints and Recommendation
6.1 IPR Protection
6.2 Regulatory Issues
6.3 Reimbursement Issues
6.4 Low Investments in R&D
7. Competitive Landscape
7.1 GlaxoSmithKline plc
7.2 Pfizer Inc
7.3 Sanofi-Aventis
7.4 Ranbaxy Laboratories Limited
7.5 Takeda Pharmaceutical Company Limited
Read More...
